Tumor ICD is accompanied by the release of damage-associated molecular patterns (DAMPs), including the exposure of calreticulin (CRT), secretion of adenosine triphosphate (ATP), and release of high mobility group protein B1 (HMGB1)2–6. This evidence concerns the gene HMGB1 and neoplasm.